Skip to main content
Fuan Pharmaceutical （Group）co.,Ltd logo

Fuan Pharmaceutical （Group）co.,Ltd — Investor Relations & Filings

Ticker · 300194 ISIN · CNE1000011G4 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,014 across all filing types
Latest filing 2018-12-03 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 300194

About Fuan Pharmaceutical （Group）co.,Ltd

https://www.fapharm.com

Fuan Pharmaceutical (Group) Co., Ltd. is an integrated pharmaceutical enterprise specializing in the research, development, production, and distribution of a wide range of chemical drugs. The company operates across the entire value chain, encompassing pharmaceutical intermediates, active pharmaceutical ingredients (APIs), and finished dosage forms. Its product portfolio primarily focuses on anti-infectives, particularly cephalosporins and penicillins, as well as treatments for cardiovascular diseases, oncology, and respiratory conditions. Fuan Pharmaceutical maintains large-scale manufacturing facilities and emphasizes technological innovation to support its diverse pipeline of generic and specialized medications. The group serves both domestic and international markets, providing essential healthcare solutions through its network of subsidiaries and specialized production bases.

Recent filings

Filing Released Lang Actions
独立董事提名人声明（三）
Board/Management Information Classification · 95% confidence The document is a formal statement from the board of directors nominating an independent director candidate for the company's board. It includes detailed declarations about the nominee's qualifications, compliance with various regulatory requirements, and independence criteria. There is no financial data, earnings information, or report publication mentioned. The content focuses on board/management information, specifically the nomination of a board member. Therefore, the document fits best under the category of Board/Management Information (MANG). The document length and detail support this classification with high confidence.
2018-12-03 Chinese
关于选举产生第四届监事会职工代表监事的公告
Board/Management Information Classification · 95% confidence The document is an announcement regarding the election of a new employee representative supervisor to the company's supervisory board. It includes details about the election process, the term of the supervisory board, and a brief biography of the elected individual. There is no financial data, no mention of financial results, no regulatory certifications, or report publications. The content focuses on board/management changes specifically related to the supervisory board member election. Therefore, it fits best under the category of Board/Management Information (MANG). The document length is short and it is not a report publication announcement or regulatory filing. Hence, the classification is MANG with high confidence.
2018-12-03 Chinese
关于监事会换届选举的公告
Board/Management Information Classification · 95% confidence The document is an announcement regarding the election of the supervisory board members (监事会换届选举) of the company 福安药业（集团）股份有限公司. It details the nomination of candidates for the supervisory board and the procedures for their election at the shareholders' meeting. There is no financial data, audit information, or report content. The document focuses on changes in the company's supervisory board, which is part of the company's governance structure. This fits the category of Board/Management Information (MANG), which includes announcements of changes in the company's board or senior management. The document length is short (1484 characters), and it is not a report publication announcement or certification. Therefore, the correct classification is MANG with high confidence.
2018-12-03 Chinese
独立董事关于第三届董事会第二十五次会议有关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent directors' opinion statement regarding matters discussed at the company's third board meeting, including board member elections, guarantees for subsidiary financing, and shareholder commitment waivers. It references compliance with regulatory guidelines and laws but does not contain financial statements or detailed financial data. The document is a formal opinion or statement related to board and governance matters rather than a full report or announcement of financial results. Therefore, it fits best under Board/Management Information (MANG), which covers announcements of changes or opinions related to the company's board or senior management.
2018-12-03 Chinese
独立董事候选人声明（熊文说）
Board/Management Information Classification · 95% confidence The document is a detailed declaration by an independent director candidate of a company, confirming compliance with various legal and regulatory requirements for serving as an independent director. It includes statements about qualifications, independence, and adherence to relevant laws and regulations. There is no financial data, no report of financial performance, no voting results, no management changes, no earnings information, or any other financial or corporate event disclosures. The document is a formal declaration related to board/management information, specifically about the appointment or candidacy of an independent director. Therefore, the most appropriate classification is 'Board/Management Information' (MANG). The document length (5631 characters) supports it being a full declaration rather than a brief announcement or notice.
2018-12-03 Chinese
独立董事提名人声明（一）
Board/Management Information Classification · 95% confidence The document is a formal public statement from the board of directors of 福安药业（集团）股份有限公司 nominating an individual as an independent director candidate. It contains detailed declarations about the nominee's qualifications, compliance with various regulatory requirements, and independence criteria. There is no financial data, earnings information, or report publication mentioned. The content focuses on board/management changes, specifically the nomination of a new independent director. This fits the category of Board/Management Information (MANG). The document length is about 5510 characters, which is sufficient for a detailed nomination statement rather than a brief announcement or certification.
2018-12-03 Chinese

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.